ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,045.98
      1.37%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      02/24/20124:12PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/24/20124:12PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/23/20126:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the RBC Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/22/20128:28AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/22/20126:00AMPR Newswire (US)Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 Fourth Quarter and Full Year Financial ResultsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/17/20124:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/16/20126:31PMPR Newswire (US)Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012NASDAQ:LXRXLexicon Pharmaceuticals Inc
      02/07/20126:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/09/20124:30PMPR Newswire (US)LX4211 Enhances Effects of DPP-4 Inhibition in Patients with Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      01/04/20126:00PMPR Newswire (US)Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/30/20114:11PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/27/20115:24PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/27/20114:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/27/20114:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/27/20114:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      12/23/20118:30AMPR Newswire (US)Lexicon Announces Completion of Rights Offering to StockholdersNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/22/20114:07PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/22/20118:38AMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/22/20116:00AMPR Newswire (US)Lexicon Announces Commencement of Rights Offering to StockholdersNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/14/201110:04AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/11/20116:00PMPR Newswire (US)Lexicon Announces Plans for Rights Offering to StockholdersNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/09/20116:00AMPR Newswire (US)LX2931 Phase 2 Data to be Presented at the American College of Rheumatology ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/08/20116:01AMEdgar (US Regulatory)Notice of Effectiveness (EFFECT)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/03/20116:00PMPR Newswire (US)Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      11/03/20115:20PMEdgar (US Regulatory)Post-Effective Amendment to Registration Statement (POS AM)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX